Adverse respiratory events associated with hypnotics use in patients of chronic obstructive pulmonary disease

Medicine (United States)

Volumn 94, Issue 27, 2015, Pages e1110-

  Chung, Wei Sheng ^a,b,c   Lai, Ching Yuan ^d   Lin, Cheng Li ^d,e   Kao, Chia Hung ^d,e  

^a Taichung Hospital   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; HYPNOTIC AGENT; HYPNOTIC SEDATIVE AGENT;

AGED; ALCOHOL RELATED DISEASE; ARTICLE; CARDIOPULMONARY ARREST; CASE CONTROL STUDY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEMENTIA; DISEASE EXACERBATION; DISEASES; FEMALE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; RISK ASSESSMENT; ADULT; LUNG DISEASE; MIDDLE AGED; ODDS RATIO; PATHOPHYSIOLOGY; SLEEP WAKE DISORDERS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; LUNG DISEASES; MALE; MIDDLE AGED; ODDS RATIO; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SLEEP WAKE DISORDERS;

EID: 84941040456     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000001110     Document Type: Article

References (39)

1. Ohayon MM, Hong SC. Prevalence of insomnia and associated factors in South Korea. J Psychosom Res. 2002; 53: 593-600
2. Mai E, Buysse DJ. Insomnia: prevalence, impact, pathogenesis, differential diagnosis, and evaluation. Sleep Med Clin. 2008; 3: 167-174
3. Chung WS, Lin CL, Chen YF, et al. Sleep disorders and increased risk of subsequent acute coronary syndrome in individuals without sleep apnea: a nationwide population-based cohort study. Sleep. 2013; 36: 1963-1968
4. Wallander MA, Johansson S, Ruigomez A, et al. Morbidity associated with sleep disorders in primary care: a longitudinal cohort study. Prim Care Companion J Clin Psychiatry. 2007; 9: 338-345
5. Klink M, Quan SF. Prevalence of reported sleep disturbances in a general adult population and their relationship to obstructive airways diseases. Chest. 1987; 91: 540-546
6. Budhiraja R, Parthasarathy S, Budhiraja P, et al. Insomnia in patients with COPD. Sleep. 2012; 35: 369-375
7. Bellia V, Catalano F, Scichilone N, et al. Sleep disorders in the elderly with and without chronic airflow obstruction: the SARA study. Sleep. 2003; 26: 318-323
8. Cormick W, Olson LG, Hensley MJ, et al. Nocturnal hypoxaemia and quality of sleep in patients with chronic obstructive lung disease. Thorax. 1986; 41: 846-854
9. Valipour A, Lavie P, Lothaller H, et al. Sleep profile and symptoms of sleep disorders in patients with stable mild to moderate chronic obstructive pulmonary disease. Sleep Med. 2011; 12: 367-372
10. Leger D, Morin CM, Uchiyama M, et al. Chronic insomnia, qualityof-life, and utility scores: comparison with good sleepers in a crosssectional international survey. Sleep med. 2012; 13: 43-51
11. Hynninen MJ, Pallesen S, Hardie J, et al. Insomnia symptoms, objectively measured sleep, and disease severity in chronic obstructive pulmonary disease outpatients. Sleep Med. 2013; 14: 1328-1333
12. Putman-Casdorph H, McCrone S. Chronic obstructive pulmonary disease, anxiety, and depression: state of the science. Heart Lung. 2009; 38: 34-47
13. Siriwardena AN, Apekey T, Tilling M, et al. General practitioners'preferences for managing insomnia and opportunities for reducing hypnotic prescribing. J Eval Clin Pract. 2010; 16: 731-737
14. Glass J, Lanctot KL, Herrmann N, et al. Sedative hypnotics in older people with insomnia: meta-Analysis of risks and benefits. BMJ. 2005; 331: 1169
15. Vozoris NT, Fischer HD, Wang X, et al. Benzodiazepine use among older adults with chronic obstructive pulmonary disease: a population-based cohort study. Drugs Aging. 2013; 30: 183-192
16. National Health Insurance Administration, Ministry of Health and Welfare. National Health Insurance Administration. 2014. http://www.nhi.gov.tw/english/index.aspx. Accessed October 21, 2014
17. Chung WS, Lin CL, Ho FM, et al. Asthma increases pulmonary thromboembolism risk: a nationwide population cohort study. Eur Respir J. 2014; 43: 801-807
18. Shen TC, Chung WS, Lin CL, et al. Does chronic obstructive pulmonary disease with or without type 2 diabetes mellitus influence the risk of lung cancer?. Result from a population-based cohort study. PLoS One. 2014; 9: e98290
19. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40: 373-383
20. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992; 45: 613-619
21. Vozoris NT, Fischer HD, Wang X, et al. Benzodiazepine drug use and adverse respiratory outcomes among older adults with COPD. Eur Respir J. 2014; 44: 332-340
22. Mendelson WB, Martin JV, Rapoport DM. Effects of buspirone on sleep and respiration. Am Rev Respir Dis. 1990; 141: 1527-1530
23. Zhang XJ, Li QY, Wang Y, et al The effect of non-benzodiazepine hypnotics on sleep quality and severity in patients with OSA: a meta-Analysis. Sleep Breath. 2014; 18: 781-789
24. Wagner J, Wagner ML. Non-benzodiazepines for the treatment of insomnia. Sleep Medicine Rev. 2000; 4: 551-581
25. Roth T. Hypnotic use for insomnia management in chronic obstructive pulmonary disease. Sleep Med. 2009; 10: 19-25
26. McNicholas WT, Verbraecken J, Marin JM. Sleep disorders in COPD: the forgotten dimension. Eur Respir Rev. 2013; 22: 365-375
27. Gay PC. Chronic obstructive pulmonary disease and sleep. Respir Care. 2004; 49: 39-51discussion 2
28. Stege G, Vos PJ, van den Elshout FJ, et al. Sleep, hypnotics and chronic obstructive pulmonary disease. Respir Med. 2008; 102: 801-814
29. Cohn MA, Morris DD, Juan D. Effects of estazolam and flurazepam on cardiopulmonary function in patients with chronic obstructive pulmonary disease. Drug Saf. 1992; 7: 152-158
30. Beaupre A, Soucy R, Phillips R, et al. Respiratory center output following zopiclone or diazepam administration in patients with pulmonary disease. Respiration. 1988; 54: 235-240
31. Calverley PM, Brezinova V, Douglas NJ, et al The effect of oxygenation on sleep quality in chronic bronchitis and emphysema. Am Rev Respir Dis. 1982; 126: 206-210
32. Sleep problems in COPD. American Thoracic Society. 2014. Accessed September 25, 2014
33. Mulloy E, McNicholas WT. Theophylline improves gas exchange during rest, exercise, and sleep in severe chronic obstructive pulmonary disease. Am Rev Respir Dis. 1993; 148: 1030-1036
34. Martin RJ, Bartelson BL, Smith P, et al. Effect of ipratropium bromide treatment on oxygen saturation and sleep quality in COPD. Chest. 1999; 115: 1338-1345
35. Morin CM, Colecchi C, Stone J, et al. Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial. JAMA. 1999; 281: 991-999
36. Kapella MC, Herdegen JJ, Perlis ML, et al. Cognitive behavioral therapy for insomnia comorbid with COPD is feasible with preliminary evidence of positive sleep and fatigue effects. Int J Chron Obstruct Pulmon Dis. 2011; 6: 625-635
37. Fried L, Bernardini J, Piraino B. Charlson comorbidity index as a predictor of outcomes in incident peritoneal dialysis patients. Am J Kidney Dis. 2001; 37: 337-342
38. Ouellette JR, Small DG, Termuhlen PM. Evaluation of Charlson-Age Comorbidity Index as predictor of morbidity and mortality in patients with colorectal carcinoma. J Gastrointest Surg. 2004; 8: 1061-1067
39. Global strategy for the diagnosis, management, and prevention of COPD updated 2014. GOLD committees. 2014. Accessed October 17, 2014